Virupaksha Organics Ltd.: A Leading Producer of Fexofenadine HCl

Virupaksha Organics Ltd. has solidified its position as a key player in the global pharmaceutical industry, particularly in the production of Fexofenadine Hydrochloride (HCl), a widely used antihistamine for treating allergy symptoms. With cutting-edge manufacturing facilities in Telangana, India, Virupaksha adheres to the highest international standards of quality and compliance, ensuring the production of top-quality Fexofenadine HCl for both domestic and international markets.
Virupaksha’s facilities are certified by WHO-GMP, ISO 9001, and ISO 14001, which attests to the company’s commitment to maintaining rigorous quality control and environmental management. The company’s production capabilities and advanced R&D enable it to deliver cost-effective, high-purity APIs that meet the growing global demand for Fexofenadine HCl.
With its focus on innovation, sustainability, and customer satisfaction, Virupaksha Organics continues to be a trusted partner for pharmaceutical companies worldwide. Its strategic approach to producing APIs like Fexofenadine HCl positions the company as a leader in the antihistamine market, contributing to improved healthcare outcomes for millions of patients globally.
As the demand for allergy medications rises, Virupaksha Organics remains at the forefront of API production, demonstrating excellence in pharmaceutical manufacturing and reinforcing its status as a premier producer of Fexofenadine HCl.

Other Latest News
- Pharma Pulse 3/31/25: Bridging the HCP-Patient Divide, Kennedy Proposes Massive Reorganization, Staff Cuts at HHS & more March 31, 2025 11:40 am Pharmaceutical Commerce The Evolution of Healthcare Communication: Bridging the HCP-Patient Divide In a world riddled with misinformation online, trust-building between healthcare providers (HCPs) and their patients has become more important than ever. Being ill is stressful …
- BridgeBio Pharma's Beyonttra to treat transthyretin─mediated amyloid cardiomyopathy receives Japanese approval March 31, 2025 11:38 am Pharmabiz.com BridgeBio Pharma, Inc., a new type of biopharmaceutical company focused on genetic diseases, announced the Japanese Ministry of Health, Labour and Welfare has approved acoramidis, under the brand name Beyonttra, for the treatment of adults with …
- HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners March 31, 2025 11:22 am WFMZ – Pennsylvania This major acquisition in Ticino will allow the two companies to combine their forces of production, chemical and biological expertise, know-how and technological capabilities, creating new opportunities of growth and driving business development to …
- PMLiVE’s Top Pharma list – results and predictions for global drug sales March 31, 2025 11:20 am PMLiVE PMLiVE’s Top Pharma list has launched, ranking the top companies in the pharmaceutical industry by their global sales, as well as by their revenues in the US, Europe and Japan. Each company listed has its own profile page, featuring graphs for each of the …
- Menzies Aviation records $2.6 billion revenue across global operations March 31, 2025 10:59 am STAT Trade Times Menzies Aviation reported revenue of $2.6 billion for 2024, a year-on-year increase of 20 percent on expansion in existing and new markets. "The group also reported a robust EBITDA of $382 million with a 15 percent margin, illustrating the strength of …
- Korea slips to 6th in global clinical trials, as Beijing overtakes Seoul March 31, 2025 9:41 am Korea Biomedical Review Korea has slipped to sixth place globally in the share of pharmaceutical industry-led clinical trials, according to data compiled by the Korea Drug Development Fund. As of 2024, Korea accounted for 3.46 percent of global clinical trials initiated by …
- Boryung CEO charts bold future with space healthcare vision, reinforces pharma core March 31, 2025 7:44 am Korea Biomedical Review Boryung, which surpassed 1 trillion won ($679.8 million) in annual revenue last year, has reaffirmed its commitment to strengthening its core pharmaceutical business while aggressively investing in space medicine as a strategic growth engine. At its 61st …
- Trump's tariff war threatens to disrupt pharma supply chain March 31, 2025 7:21 am Biospectrum Asia Trump's tariff war threatens to disrupt pharma supply chain March 31, 2025 | Monday | Analysis | By Ayesha Siddiqui After pulling US funding from the World Health Organisation (WHO), the US President Donald Trump has now announced a 25 per cent tariff …
- Abu Dhabi prepares to welcome global health leaders to Abu Dhabi Global Health Week 2025 March 31, 2025 5:05 am Eye of Riyadh Abu Dhabi Global Health Week (ADGHW) 2025 is set to welcome prominent health and well-being industry leaders for three days of open, exclusive exchange and joint action from 15 – 17 April. Held under the patronage of His Highness Sheikh Khaled bin Mohamed …
- Taoiseach Micheál Martin highlights food, drinks and pharma in EU meeting as Donald Trump tariffs loom March 31, 2025 3:07 am Irish Independent Mr Martin said that there had been a “useful and constructive call” with Ms von der Leyen, who “outlined her expectations for developments on tariffs this week”. Several Irish ministers have expressed deep concern over how exposed Ireland is to possible …
- Taoiseach highlights food, drink and pharma industry as Trump’s tariffs loom large over Europe March 30, 2025 7:03 pm Irish Independent Mr Martin said that there had been a “useful and constructive call” with the European Commission President, who “outlined her expectations for developments on tariffs this week”. Several Irish ministers have expressed deep concern over how exposed Ireland …
- Short Acting Insulin Global Market Report 2025: Projected To Reach $14.47 Billion With A CAGR Of 5.6% March 30, 2025 5:36 pm EIN Presswire Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout. LONDON, GREATER LONDON, UNITED KINGDOM, March 31, 2025 /EINPresswire.com/ — In recent years, the short-acting insulin market size has displayed strong growth. …
- US tariff threat on Indian generics: What it means for pharma March 30, 2025 5:17 pm The Economic Times Around 40% of generic drugs consumed in the US are imported from India. Nobody knows if, or by how much, these drugs could become dearer after April 2. Currently, the US imposes no tariffs on Indian pharma. Should they do so, and if they are punitive, …
- Global Sepsis Market Forecast 2025-2034: Analyzing Growth Drivers, Market Share, Segments, And Emerging Trends March 30, 2025 5:03 pm EIN Presswire Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout. LONDON, GREATER LONDON, UNITED KINGDOM, March 31, 2025 /EINPresswire.com/ — The robust growth of the sepsis market is setting a promising trend for the future …
- KKR partly sells its JB Pharma equity stake: It missed a better opportunity March 30, 2025 12:50 pm ETPharma.com Mumbai: Last week, global investment firm KKR partly exited Mumbai-based drug maker JB Pharma, selling a 5.8 per cent stake for Rs 1,460 crore through open market transactions. The deal valued each JB share at Rs 1,625. In 2020, KKR shelled out about Rs 3, …
- US Tariff, PMI, FIIs And Global Economic Data Key Triggers For Next Week March 30, 2025 6:25 am Zee News New Delhi: The market outlook for next week will be guided by several domestic and global economic factors such as PMI and FIIs data, auto sales and Key US economic data, including the Composite PMI and Initial Jobless Claims. On the domestic front, auto …
- Innate Pharma S.A. (NASDAQ:IPHA) Q4 2024 Earnings Call Transcript March 29, 2025 12:13 pm Insider Monkey Innate Pharma S.A. (NASDAQ:IPHA) Q4 2024 Earnings Call Transcript March 27, 2025 Innate Pharma S.A. misses on earnings expectations. Reported EPS is $-0.33474 EPS, expectations were $-0.26681. Operator: Hello, and welcome to the Innate Pharma Full Year …
- ‘Abu Dhabi Global Health Week 2025’ set to kick off on April 15 March 29, 2025 8:38 am GCC Business News Abu Dhabi Global Health Week (ADGHW) 2025 is set to kick off from April 15-17, gathering leading health and well-being leaders to drive health transformation on a global scale. The event, held under the patronage of H.H. Sheikh Khaled bin Mohamed bin Zayed …
- Trump to announce pharma tariffs soon March 29, 2025 1:54 am The Economic Times U.S. President Donald Trump said on Friday that he would soon announce tariffs targeting the pharmaceutical industry but did not provide details on timing or rates. Speaking to reporters aboard Air Force One, Trump also stated that he was open to …
- Novo Nordisk Lands Lexicon Pharma Obesity Drug With Potential to Pair With GLP-1s March 28, 2025 7:39 pm MedCity News Novo Nordisk has been on the hunt for differentiated obesity drugs that could complement its blockbuster GLP-1 agonist, Wegovy. It’s found a contender with preclinical data indicating it can lead to greater weight loss as part of a drug combination and …
- The Multifaceted Future of Pharma – Chapter 7: Getting Smarter With Manufacturing March 28, 2025 6:40 pm The Medicine Maker Read on for views on why sustainability, automation, AI, data and continuous processing will shape the future of manufacturing in the industry. We asked: What has/have been the key disruptor(s) driving the industry over the past ten years, and how will …
- Senate investigation claims Pfizer shifted profits offshore in what could be pharma's 'largest tax-dodging scheme' March 28, 2025 5:50 pm Fierce Pharma Four years into a Congressional probe of Big Pharma’s potential abuse of a 2017 tax break, Democratic lawmakers have homed in on Pfizer, accusing the New York drugmaker of some of the most egregious financial maneuvering they’ve uncovered. By shifting …
- NCLT approves Suven Pharma and Cohance Lifesciences Merger March 28, 2025 3:08 pm ETPharma.com Hyderabad: The National Company Law Tribunal (NCLT) has approved the scheme of amalgamation between Cohance Lifesciences and Suven Pharmaceuticals, allowing both companies to proceed with their merger plans and obtain the necessary regulatory approvals. In …
- Promoter KKR sells 5.8 pc stake in JB Chemicals & Pharma for Rs 1,460 crore March 28, 2025 3:08 pm ETPharma.com New Delhi: Global investment firm KKR on Thursday divested a 5.8 per cent stake in JB Chemicals & Pharmaceuticals for Rs 1,460 crore through open market transactions. New York-based KKR offloaded shares in four separate transactions on the National …
- Spinal Stenosis Treatment Global Market Report 2025: Highlights, Forecasts And Key Players March 28, 2025 2:17 pm EIN Presswire Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout. LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /EINPresswire.com/ — The spinal stenosis treatment market has seen consistent growth in recent years. …